AB science

PharmaShots Weekly Snapshots (May 31 – June 4, 2021)

AB science, AbbVie, Alnylam, Amgen, AstraZeneca, Bio-Thera, Biogen, Biohaven, BioNTech, BMS, BridgeBio, Celltrion, Dermavant, Helsinn, Innovent, Ipsen, Janssen, Kyowa Kirin, Lilly, Lupin, Merck, MorphoSys, Novartis, Novo Nordisk, Pfizer, Sanofi, Santhera, Tonix Pharmaceuticals, United Therapeutics, Weekly Snapshot / June 4, 2021 June 4, 2021

Tonix Pharmaceuticals Presents Results of TNX-102 SL in P-III RELIEF study for the Management of Fibromyalgia at ASCP 2021 Published: June 4, 2021 | Tags: Tonix Pharmaceuticals, TNX-102 SL, P-III, RELIEF Study, Fibromyalgia, ASCP 2021 Dermavant Submits NDA to the US FDA for Tapinarof Cream to Treat Plaque Psoriasis Published: June 4, 2021 | Tags: …

PharmaShots Weekly Snapshots (May 31 – June 4, 2021) Read More »

AB Science Holds the Clinical Studies of Masitinib Globally

AB science, Clinical Studies, Clinical Trials, Discontinues, Globally, Masitinib / June 1, 2021 June 1, 2021

Shots: The company holds the inclusion and initiation of treatment in ongoing 3 studies i.e P-III in mastocytosis (AB15003), P-III study in AML (AB19001) & P-II in COVID (AB20001) for masitinib, until the investigation of safety issue is completed The decision follows discussions with the French regulatory authorities (ANSM) and other regulatory agencies. The company …